Literature DB >> 10618290

Homocysteine and laminin are not prognostic markers in patients with septic inflammatory response syndrome.

B Stoiser1, F Thalhammer, I El-Menyawi, A Wilfing, F Daxböck, G J Locker, H Burgmann.   

Abstract

The aim of this study was to measure plasma homocysteine and laminin concentrations in patients with nonbacteremic systemic inflammatory response syndrome (SIRS) and to compare them with those of a healthy control group. Concerning laminin, significant increased concentrations could be observed in the SIRS group compared to the control group, but for homocysteine, no significance could be observed. In summary, homocysteine and laminin levels are not useful in the prediction of a patient's outcome.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10618290      PMCID： PMC95835          DOI： 10.1128/CDLI.7.1.119-121.2000

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


  17 in total

1.  Laminin--a glycoprotein from basement membranes.

Authors:  R Timpl; H Rohde; P G Robey; S I Rennard; J M Foidart; G R Martin
Journal:  J Biol Chem       Date:  1979-10-10       Impact factor: 5.157

2.  Markers of collagen and basement membrane metabolism in sera of patients with progressive systemic sclerosis.

Authors:  N G Guseva; N V Anikina; R Myllylä; L Risteli; J Risteli; J V Chochlova; K I Kivirikko; V A Nassonova
Journal:  Ann Rheum Dis       Date:  1991-07       Impact factor: 19.103

3.  Measurement of serum nitrite/nitrate concentrations using high-performance liquid chromatography.

Authors:  I El Menyawi; S Looareesuwan; S Knapp; F Thalhammer; B Stoiser; H Burgmann
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1998-03-20

Review 4.  Vascular disease in scleroderma. Endothelial T lymphocyte-fibroblast interactions.

Authors:  M B Kahaleh
Journal:  Rheum Dis Clin North Am       Date:  1990-02       Impact factor: 2.670

5.  Serum laminin in Graves' disease.

Authors:  C Wenisch; D Myskiw; E Narzt; E Presterl; W Graninger
Journal:  Eur J Clin Invest       Date:  1995-06       Impact factor: 4.686

6.  Serum concentration of laminin, and course of the disease in patients with various malignancies.

Authors:  C Rochlitz; C Hasslacher; D G Brocks; R Herrmann
Journal:  J Clin Oncol       Date:  1987-09       Impact factor: 44.544

7.  Serum laminin--its concentration increases with portal hypertension in cirrhotic liver disease.

Authors:  A M Gressner; W Tittor
Journal:  Klin Wochenschr       Date:  1986-12-01

8.  Interleukin-1-beta activation of cultured glomerular epithelial cells.

Authors:  A Moutabarrik; I Nakanishi; D Zaid; M Namiki; N Kawaguchi; S Onishi; M Ishibashi; A Okuyama
Journal:  Exp Nephrol       Date:  1994 May-Jun

Review 9.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

Authors:  R C Bone; R A Balk; F B Cerra; R P Dellinger; A M Fein; W A Knaus; R M Schein; W J Sibbald
Journal:  Chest       Date:  1992-06       Impact factor: 9.410

10.  The use of risk predictions to identify candidates for intermediate care units. Implications for intensive care utilization and cost.

Authors:  J E Zimmerman; D P Wagner; W A Knaus; J F Williams; D Kolakowski; E A Draper
Journal:  Chest       Date:  1995-08       Impact factor: 9.410
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.